Medications for Diabetes, Type 2
Other names: Diabetes; Noninsulin-dependent Diabetes; Type 2 Diabetes
Drugs used to treat Diabetes, Type 2
The following list of medications are in some way related to or used in the treatment of this condition.
Drug name | Rating | Reviews | Activity ? | Rx/OTC | Pregnancy | CSA | Alcohol |
---|---|---|---|---|---|---|---|
metformin | 5.9 | 257 reviews | Rx | ||||
Generic name: metformin systemic Brand names: Glumetza, Riomet Drug class: non-sulfonylureas For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Januvia | 4.6 | 129 reviews | Rx | ||||
Generic name: sitagliptin systemic Drug class: dipeptidyl peptidase 4 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Ozempic | 5.6 | 593 reviews | Rx | ||||
Generic name: semaglutide systemic Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Tradjenta | 3.0 | 62 reviews | Rx | ||||
Generic name: linagliptin systemic Drug class: dipeptidyl peptidase 4 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
sitagliptin | 4.5 | 142 reviews | Rx | ||||
Generic name: sitagliptin systemic Brand name: Januvia Drug class: dipeptidyl peptidase 4 inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
Onglyza | 5.9 | 15 reviews | Rx | ||||
Generic name: saxagliptin systemic Drug class: dipeptidyl peptidase 4 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Mounjaro | 6.4 | 134 reviews | Rx | ||||
Generic name: tirzepatide systemic Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
semaglutide | 5.6 | 778 reviews | Rx | ||||
Generic name: semaglutide systemic Brand names: Ozempic, Rybelsus Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
tirzepatide | 6.5 | 136 reviews | Rx | ||||
Generic name: tirzepatide systemic Brand name: Mounjaro Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
Victoza | 7.6 | 510 reviews | Rx | ||||
Generic name: liraglutide systemic Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
glipizide | 6.1 | 67 reviews | Rx | ||||
Generic name: glipizide systemic Brand names: Glucotrol, GlipiZIDE XL, Glucotrol XL Drug class: sulfonylureas For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
glimepiride | 6.6 | 71 reviews | Rx | ||||
Generic name: glimepiride systemic Brand name: Amaryl Drug class: sulfonylureas For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Amaryl | 7.2 | 20 reviews | Rx | ||||
Generic name: glimepiride systemic Drug class: sulfonylureas For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Invokana | 5.8 | 257 reviews | Rx | ||||
Generic name: canagliflozin systemic Drug class: SGLT-2 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Lantus | 6.2 | 28 reviews | Rx | ||||
Generic name: insulin glargine systemic Drug class: insulin For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Farxiga | 4.4 | 128 reviews | Rx | ||||
Generic name: dapagliflozin systemic Drug class: SGLT-2 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Jardiance | 5.3 | 286 reviews | Rx | ||||
Generic name: empagliflozin systemic Drug class: SGLT-2 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Actos | 4.9 | 40 reviews | Rx | ||||
Generic name: pioglitazone systemic Drug class: thiazolidinediones For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Levemir | 5.5 | 37 reviews | Rx | ||||
Generic name: insulin detemir systemic Drug class: insulin For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Janumet | 6.0 | 64 reviews | Rx | ||||
Generic name: metformin / sitagliptin systemic Drug class: antidiabetic combinations For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Glucotrol | 7.4 | 9 reviews | Rx | ||||
Generic name: glipizide systemic Drug class: sulfonylureas For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Trulicity | 5.1 | 905 reviews | Rx | ||||
Generic name: dulaglutide systemic Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Byetta | 7.9 | 81 reviews | Rx | ||||
Generic name: exenatide systemic Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Glumetza | 9.5 | 4 reviews | Rx | ||||
Generic name: metformin systemic Drug class: non-sulfonylureas For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
liraglutide | 7.6 | 519 reviews | Rx | ||||
Generic name: liraglutide systemic Brand name: Victoza Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
Frequently asked questions
- What is the safest diabetes medication?
- What foods should I eat or avoid for hypoglycemia?
- Can you have hypoglycemia without diabetes?
- What is the connection between the endocrine system and osteoporosis?
- Which type of insulin has the longest duration of action?
- Can you take Ibuprofen if you have COVID-19 (coronavirus)?
- How long does it take for Ozempic to work?
Alternative treatments for Diabetes, Type 2
The following products are considered to be alternative treatments or natural remedies for Diabetes, Type 2. Their efficacy may not have been scientifically tested to the same degree as the drugs listed in the table above. However there may be historical, cultural or anecdotal evidence linking their use to the treatment of Diabetes, Type 2.
Learn more about Diabetes, Type 2
- Diabetes Medications and Alcohol Interactions
- Diabetes, Type 2 Health Article
- OneTouch Blood Glucose Meters
- Top 10 Diabetes Treatments You May Have Missed
- What is Insulin Resistance?
- Which Drugs Cause Weight Gain?
Care guides
- Diabetes and your Skin
- Diabetic Gastroparesis
- Diabetic Hyperglycemia
- Diabetic Kidney Disease
- Diabetic Neuropathy
- How to Draw Up Insulin
- Hypoglycemia in a Person with Diabetes
Symptoms and treatments
Medicine.com guides (external)
Legend
Rating | For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |
---|---|
Activity | Activity is based on recent site visitor activity relative to other medications in the list. |
Rx | Prescription only. |
OTC | Over-the-counter. |
Rx/OTC | Prescription or Over-the-counter. |
Off-label | This medication may not be approved by the FDA for the treatment of this condition. |
EUA | An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives. |
Expanded Access | Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
N | FDA has not classified the drug. |
Controlled Substances Act (CSA) Schedule | |
---|---|
M | The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication. |
U | CSA Schedule is unknown. |
N | Is not subject to the Controlled Substances Act. |
1 | Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
2 | Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
3 | Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
5 | Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Alcohol | |
---|---|
X | Interacts with Alcohol. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.